Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER Free Speech Response Complicated By Family Ties

This article was originally published in RPM Report

Executive Summary

It’s hard enough for FDA to try to chart its course on promotional claims in the face of shifting opinions in the courts. Now, the CDER management team has to deal with a change in leadership of one of the key internal groups monitoring the issue.

Advertisement

Related Content

FDA Taps NIH Veteran Corrigan-Curay To Lead Medical Policy Office

Topics

Advertisement
UsernamePublicRestriction

Register

PS079784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel